The hair loss world is buzzing about Histogen’s small, but impressive pilot clinical trial. Despite some much talked about setbacks, it looks like it’s “all systems go” for the San Diego based startup.
Last year Histogen was forced to layoff thirty six of it’s employees after its fundraising efforts were stifled when a rival company located in Carlsbad, CA called SkinMedica, filed a patent infringement lawsuit against the the company. While the case is still pending, Histogen’s founder and CEO, Dr. Gail Naughten was still able to raise enough cash to keep her core group of researchers and employees on the job. Naughton states that Histogen has also received the substantial funding needed to underwrite the additional studies that are soon to take place in Singapore.
The hair loss community has its collective fingers crossed, as is illustrated by the tone of last weeks Tuesday night TBT broadcast.
Here’s a segment:
